In the biotech context, VIVALIS has an established track record: over two decades of operations, multiple major partnerships, and a diversified business model balancing licensing and R&D. This gives some legitimacy to its technology platforms (EB66®, Humalex®, 3D‑Screen™) and implies real scientific infrastructure. https://www.youtube.com/watch?v=O4r8pNhOjzw